Intraoperative Ultrasonographic Localization of Pulmonary Nodules in VATS
Launched by SHANGHAI CHEST HOSPITAL · Jul 23, 2018
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
The study is designed as a single center prospective trial. The participating center is Department of Ultrasound, Shanghai Chest Hospital, Shanghai Jiao Tong University, China. The study is expected to enroll 200 patients. The feasibility and value of Intraoperative ultrasonographic localization of pulmonary nodules in VATS will be explored. The accuracy rate of localization will be evaluated using gray scale mode and elastography mode. Intraoperative ultrasonographic localization will be performed using an ultrasound system (HI VISON Ascendus), which is equipped with a 5-10MHz mechanical p...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients who are older than 18 year-old.
- • 2. Chest CT shows pulmonary nodule suspected to be malignant that need to undergo VATS.
- • 3. Patients who have good compliance and sign informed consent.
- Exclusion Criteria:
- • 1. Patient with severe asthma and pulmonary fibrosis.
- • 2. Refusal of participation.
- • 3. Severe cardiopulmonary dysfunction and other indications that can't receive VATS.
About Shanghai Chest Hospital
Shanghai Chest Hospital is a leading medical institution in China, renowned for its specialized expertise in respiratory and thoracic diseases. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and improving patient outcomes through innovative therapies and treatments. With a strong emphasis on collaboration and scientific rigor, Shanghai Chest Hospital actively engages in a variety of clinical trials aimed at exploring novel interventions and enhancing the understanding of pulmonary health. The hospital's state-of-the-art facilities and commitment to patient-centered care position it as a key player in the global research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Lei Wang, MD
Principal Investigator
Shanghai Chest Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials